Advanced search

Angiotensin I converting enzyme insertion/deletion polymorphism: Clinical implications.

B WUYTS, Joris Delanghe (UGent) and Marc De Buyzere (UGent)
(1997) ACTA CLINICA BELGICA. 52(6). p.338-349
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
WUYTS, B, Joris Delanghe, and Marc De Buyzere. 1997. “Angiotensin I Converting Enzyme Insertion/deletion Polymorphism: Clinical Implications.” Acta Clinica Belgica 52 (6): 338–349.
APA
WUYTS, B, Delanghe, J., & De Buyzere, M. (1997). Angiotensin I converting enzyme insertion/deletion polymorphism: Clinical implications. ACTA CLINICA BELGICA, 52(6), 338–349.
Vancouver
1.
WUYTS B, Delanghe J, De Buyzere M. Angiotensin I converting enzyme insertion/deletion polymorphism: Clinical implications. ACTA CLINICA BELGICA. 1997;52(6):338–49.
MLA
WUYTS, B, Joris Delanghe, and Marc De Buyzere. “Angiotensin I Converting Enzyme Insertion/deletion Polymorphism: Clinical Implications.” ACTA CLINICA BELGICA 52.6 (1997): 338–349. Print.
@article{176584,
  author       = {WUYTS, B and Delanghe, Joris and De Buyzere, Marc},
  issn         = {0001-5512},
  journal      = {ACTA CLINICA BELGICA},
  language     = {eng},
  number       = {6},
  pages        = {338--349},
  title        = {Angiotensin I converting enzyme insertion/deletion polymorphism: Clinical implications.},
  volume       = {52},
  year         = {1997},
}

Web of Science
Times cited: